Risk of business disruption and logistics delays from the spread of infectious diseases, including COVID-19
First written in FY2020-Q3. 4 of 5 entries say "Restated". Latest entry: FY2023-Q1.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2023-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
It concludes that there have been no material changes in the risks of business disruption and logistics delays caused by the spread of infectious diseases. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
It concludes that there have been no material changes in the risks of business disruption and logistics delays caused by the spread of infectious diseases. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
It concludes that there have been no material changes in the risks of business disruption and logistics delays caused by the spread of infectious diseases. - FY2021-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
It concludes that there have been no material changes in the risks of business disruption and logistics delays caused by the spread of infectious diseases. It states that the Shingu Power Plant progressed as planned without being affected by the spread of infection. - FY2020-Q3First statedAnnual report
「If officers, employees or subsidiary employees of the Group contract an infectious disease for which no treatment has yet been established, business operations may be disrupted by measures to prevent further spread, including isolating those who have had contact with infected persons, potentially affecting the Group's results. If such an infectious disease spreads widely in areas where the Group operates, logistics for materials and fuel required by the Group's businesses may be disrupted, or operations may be hindered by restrictions imposed or requested by government authorities, potentially affecting the Group's results.」
The Company discloses as a new risk the potential impact on operations and results of infection and isolation, stalled logistics for materials and fuel, and government restrictions. The disclosure does not state that infection or logistics disruption has occurred within the Group.